The CMD alphaBET® system is a fully integrated endotoxin testing system providing end-users with a more rapid and sustainable solution to endotoxin testing without compromising on sensitivity or performance. Using just a few microlitres of FDA-licensed turbidimetric LAL reagent, quantitative results are provided in under half the time of other testing formats with minimal user input. AlphaBET® delivers a pharmacopoeia compliant endotoxin test, with on-board FDA part 11 ready software package ensuring data integrity. The alphaBET® system is suited to both in-process and final product testing across pharmaceutical manufacturing sites, quality control laboratories as well as in research and development facilities.

Speaker: Dr Jenna Bowen, Senior Executive Officer, Cotton Motton Diagnostics 

A Pharmacist by training, Jenna co-founded Cotton Mouton Diagnostics (CMD) to exploit a novel magneto-optical sensing platform that she and colleagues at Cardiff and Exeter Universities had developed. CMD’s first product, the alphaBET® system, offers a robust and sensitive solution for endotoxin testing in the pharmaceutical industry. Jenna has been recognised several times as a ‘rising star’ within the business world and was named one of Innovate UK’s Women in Innovation.

Location: UK Presentation Theatre: Hall 16, J48